Condition: Intracerebral Hemorrhage · Sponsor: Xuanwu Hospital, Beijing
TIME-ICH (TrIal of early Minimally Invasive catheter Evacuation with thrombolysis in IntraCerebral Hemorrhage) is a multicenter, randomized, adaptive clinical trial comparing best medical management to early minimally invasive surgery with thrombolysis (eMIST) in the treatment of acute spontaneous supratentorial intracerebral hemorrhage.
This description comes directly from the study's public registry record.
Tao Hong, MD, PhD · +86 10 8319 8948 · hongtao.edu@gmail.com
Shaohua Mo, MD · +86 10 8319 8948
Always discuss trial participation with your own doctor first.
| Guangdong Provincial People's Hospital | Guangdong, Yuexiu, China | Not Yet Recruiting |
| Guangde People's Hospital | Anhui, China | Not Yet Recruiting |
| Beijing Chao-Yang Hospital, Capital Medical University | Beijing, China | Not Yet Recruiting |
| Beijing Daxing District People's Hospital | Beijing, China | Recruiting |
| Beijing Fengtai You'anmen Hospital | Beijing, China | Recruiting |
| Beijing Friendship Hospital, Capital Medical University | Beijing, China | Recruiting |
| Peking University Aerospace Central Hospital | Beijing, China | Not Yet Recruiting |
| Shunyi District Hospital in Beijing | Beijing, China | Not Yet Recruiting |
| Xuanwu Hospital, Capital Medical University | Beijing, China | Recruiting |
| Bozhou city people's hospital | Bozhou, China | Not Yet Recruiting |
| Changsha Central Hospital | Changsha, China | Recruiting |
| Changzhi Medical College Affiliated Heji Hospital | Changzhi, China | Recruiting |
+ 38 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07187687